Related Experiment Video
Updated: Aug 14, 2026
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
Separating the factors in measles vaccine failure
Abstract:
Three possible reasons for failure of measles vaccine were identified as follows: (a) circulating maternal antibodies, (b) administration of non-viable vaccine, and (c) misdiagnosis. A study designed to test the role played by each of these in the high measles vaccine failure rate was carried out at the Oguntolu Street Clinic, Lagos, from October 1982 to February 1983. Failure to seroconvert was the cause of 67.7% of measles vaccine failure, particularly at ages 6-7 months, though this was not associated with high prevaccination titres. In 32.3% incorrect diagnosis was responsible. Non-viable vaccine was found not to be a reason because all vials of measles vaccine were potent at the time of administration.
Insights
Measles vaccine failure in infants is often due to not developing immunity (failure to seroconvert), especially in younger babies. Misdiagnosis also contributes significantly to vaccine failure rates.
Area of Science:
- Immunology
- Vaccinology
- Pediatric Infectious Diseases
Background:
- Measles vaccination is crucial for public health, but high failure rates have been observed.
- Understanding the causes of measles vaccine failure is essential for improving immunization program effectiveness.
Purpose of the Study:
- To investigate the primary reasons for measles vaccine failure in a specific population.
- To differentiate the contributions of maternal antibodies, vaccine viability, and misdiagnosis to vaccine failure.
Main Methods:
- A study was conducted at Oguntolu Street Clinic, Lagos, between October 1982 and February 1983.
- The study assessed factors including circulating maternal antibodies, vaccine viability, and diagnostic accuracy.
Main Results:
- Failure to seroconvert was identified as the leading cause of measles vaccine failure (67.7%), particularly in infants aged 6-7 months.
- Incorrect diagnosis accounted for 32.3% of vaccine failures.
- Administration of non-viable vaccine was ruled out as a cause, as all measles vaccine vials were confirmed potent.
Conclusions:
- Failure to seroconvert is the predominant reason for measles vaccine failure in the studied population, especially in younger infants.
- Misdiagnosis represents a significant, yet secondary, factor contributing to measles vaccine failure.
- Ensuring vaccine viability is critical, but immunological response and accurate diagnosis are key to successful measles immunization.
